Phase 3 N=905 Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants
Poliomyelitis
Primary: Seroconversion Rate at 1, 2 & 4 Weeks Interval — 253; 269; 277 Participants — p=0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=180 Magnesium Treatment on Vitamin D Metabolism in Participants Completed Personalized Prevention of Colorectal Cancer Trial
Colorectal Cancer
Primary: Comparisons of the Changes of Blood 25-Hydroxyvitamin D3 (25(OH)D3) Between Magnesium Treatment and Placebo Arm, Stratified by the Baseline 25-hydroxyvitamin D (25(OH)D)…
N/A N=70 Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer Survivors
Breast Cancer
Primary: Change in Daily Servings of Fruits and Vegetables — -0.1; 2.0 daily servings of fruits and vegetables
N/A N=72 To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting
Gingival Recession · Palate; Wound
Primary: Pain Assessment (0=No Pain to 10=Worst) — 4.2; 1.9; 2.2; 1 score on a scale
N/A N=20 CONFIDENCE Financial Education for Caregivers
Caregiver Burden · Financial Stress · Dementia
Primary: Monthly Out-of-pocket Caregiving Costs — 480 Dollars
N/A N=51 Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention
Posttraumatic Stress Disorder · Tonic Immobility Response
Primary: Posttraumatic Stress Disorder Symptoms — 30.41; 31.93 units on a scale
N/A N=813 Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy
Metastatic Breast Cancer
Primary: Real-World Progression Free Survival (rwPFS): Using Kaplan-Meier Method — 20.0 Months
N/A N=654 DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement
Smoking · Smoking, Tobacco · Smoking, Cigarette
Primary: Key Components of Shared Decision Making Process That Predict Patient-perceived Lung Cancer Screening Decision Quality — 21.5 score on a scale
Phase 1 N=64 A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses
Autoimmune Diseases
Primary: Number of Participants With Treatment-Emergent Adverse Events — 0; 0; 0; 0 participants
N/A N=25 The Acute Effect of Propionate on Energy Homeostasis
Obesity
Primary: Changes in Resting Energy Expenditure — 1.013; 1.040 kcal/min
N/A N=9 Evaluation of Implementing FLOW
Mental Health
Primary: Reach: Percent of Specialty Mental Health Patients Transitioned to Primary Care — 1.41; .77; 1.89 Percent of mental health patients — p=0.001
Phase 1 N=76 Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
Psoriasis
Primary: Number of Participants With Treatment-Emergent Adverse Events (AEs) And Serious Adverse Events (SAEs) — 3; 9; 7; 11 Participants
Phase 2 N=93 Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)
Reperfusion Injury
Primary: Peak Aspartate Aminotransferase Within First 72h Post Transplant — 1262.9; 1451.2 U/L
N/A N=60 Maternal Alcohol Reduction Intervention in South Africa [MaRISA]
Maternal; Alcohol Use, Affecting Fetus
Primary: Urine Ethylglucuronide (EtG) Testing — 0 Participants
N/A N=89 Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"
Type 2 Diabetes Mellitus
Primary: Number of Participants Who Had One or More Adverse Drug Reactions (ADRs) — 6 Participants